A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Bristol-Myers Squibb on April 23 for "Substituted bicyclic compounds useful as T cell activators" (American, Indian Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Boston Scientific Neuromodulation on April 23 for "Current generation architecture for an implantable stimulator device" (California Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Bristol-Myers Squibb on April 23 for "[1,2,4triazolo[1,5-apyridinyl substituted indole compounds" (Indian, American Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Methods and compositions for sensitization of tumor cells to immune therapy" (New York, New Jersey Inventors)
Published: April 24, 2024 by U.S. Fed News
US Patent Issued to Pfizer on April 23 for "Heteroaromatic compounds and their use as dopamine D1 ligands" (Massachusetts, Connecticut, Colorado Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count